Evaluating changes in lidocaine and opioid administration on the day of IUD insertion, 2018-2025.

Nina B Masters¹, Karen Gilbert Farrar², Brianna M Goodwin Cartwright¹, Patricia J Rodriguez¹, Duy Do¹, Nicholas L Stucky¹

¹Truveta, Inc., Bellevue Washington, WA, United States.

²Truveta, Inc., Bellevue Washington, WA, United States. Electronic address: kareng@truveta.com.

PubMed DOI

Abstract

OBJECTIVES: Intrauterine devices (IUDs) are highly effective, long-acting reversible contraceptives. The CDC updated their Selected Practice Recommendations for Contraceptive Use in August 2024, including guidance on pain management during IUD insertions. This study describes real-world trends in the use of lidocaine and opioids on the day of IUD insertion. STUDY DESIGN: This study used a subset…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.